PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Acute Lung Injury|Prevention
Interventions: DRUG: Pirfenidone/Placebo
Sponsor: Fujian Medical University Union Hospital
Collaborators: Beijing Continent Pharmaceutical Co, Ltd.